

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 7.34241384 |
| 2 | cerebellar granule cell differentiation (GO:0021707) | 7.33816851 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.59007010 |
| 4 | neuronal action potential propagation (GO:0019227) | 5.99064092 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.52599678 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.52063991 |
| 7 | cerebellar Purkinje cell differentiation (GO:0021702) | 5.51677622 |
| 8 | gamma-aminobutyric acid transport (GO:0015812) | 5.44299636 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.42138265 |
| 10 | sodium ion export (GO:0071436) | 5.36449443 |
| 11 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.33277082 |
| 12 | cellular potassium ion homeostasis (GO:0030007) | 5.31253169 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.30836073 |
| 14 | vocalization behavior (GO:0071625) | 5.28888313 |
| 15 | behavioral response to nicotine (GO:0035095) | 5.23545717 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 5.19908242 |
| 17 | cell differentiation in hindbrain (GO:0021533) | 5.10475304 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.88563588 |
| 19 | neurotransmitter secretion (GO:0007269) | 4.85450413 |
| 20 | positive regulation of synapse maturation (GO:0090129) | 4.84443018 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 4.79792053 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.75048921 |
| 23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.70363040 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.67509264 |
| 25 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.54265669 |
| 26 | glutamate secretion (GO:0014047) | 4.48708577 |
| 27 | exploration behavior (GO:0035640) | 4.40955931 |
| 28 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.40005532 |
| 29 | neuromuscular process controlling posture (GO:0050884) | 4.29000444 |
| 30 | layer formation in cerebral cortex (GO:0021819) | 4.27022799 |
| 31 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.24668826 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 4.21432320 |
| 33 | gonadal mesoderm development (GO:0007506) | 4.16820026 |
| 34 | long-term memory (GO:0007616) | 4.15851689 |
| 35 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.14506977 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.99982298 |
| 37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.98959928 |
| 38 | retinal cone cell development (GO:0046549) | 3.94883197 |
| 39 | cell communication by electrical coupling (GO:0010644) | 3.94807814 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.94766834 |
| 41 | neuromuscular process controlling balance (GO:0050885) | 3.87957417 |
| 42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.87062290 |
| 43 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.86042514 |
| 44 | neurotransmitter transport (GO:0006836) | 3.78310185 |
| 45 | potassium ion import (GO:0010107) | 3.72127854 |
| 46 | establishment of nucleus localization (GO:0040023) | 3.63394153 |
| 47 | dendrite morphogenesis (GO:0048813) | 3.61663658 |
| 48 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.59453729 |
| 49 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.57120291 |
| 50 | fucose catabolic process (GO:0019317) | 3.54685372 |
| 51 | L-fucose metabolic process (GO:0042354) | 3.54685372 |
| 52 | L-fucose catabolic process (GO:0042355) | 3.54685372 |
| 53 | auditory receptor cell stereocilium organization (GO:0060088) | 3.54654593 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.54632939 |
| 55 | regulation of synapse maturation (GO:0090128) | 3.54496628 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.53546218 |
| 57 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.52718251 |
| 58 | membrane depolarization during action potential (GO:0086010) | 3.51907619 |
| 59 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.49370652 |
| 60 | serotonin metabolic process (GO:0042428) | 3.47947291 |
| 61 | neuron cell-cell adhesion (GO:0007158) | 3.46467904 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.45514576 |
| 63 | potassium ion homeostasis (GO:0055075) | 3.44669659 |
| 64 | protein localization to synapse (GO:0035418) | 3.44244360 |
| 65 | adult walking behavior (GO:0007628) | 3.42680411 |
| 66 | positive regulation of synapse assembly (GO:0051965) | 3.41762499 |
| 67 | short-term memory (GO:0007614) | 3.41082339 |
| 68 | cellular sodium ion homeostasis (GO:0006883) | 3.40026539 |
| 69 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.36573486 |
| 70 | detection of light stimulus involved in visual perception (GO:0050908) | 3.36573486 |
| 71 | regulation of synapse structural plasticity (GO:0051823) | 3.36309384 |
| 72 | glycine transport (GO:0015816) | 3.33476009 |
| 73 | regulation of postsynaptic membrane potential (GO:0060078) | 3.33392288 |
| 74 | primary amino compound metabolic process (GO:1901160) | 3.32264337 |
| 75 | negative regulation of microtubule polymerization (GO:0031115) | 3.31175323 |
| 76 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.29962688 |
| 77 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.28764745 |
| 78 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.28191097 |
| 79 | regulation of neurotransmitter secretion (GO:0046928) | 3.27825307 |
| 80 | dendritic spine morphogenesis (GO:0060997) | 3.27731162 |
| 81 | positive regulation of membrane potential (GO:0045838) | 3.25638745 |
| 82 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.21424734 |
| 83 | activation of protein kinase A activity (GO:0034199) | 3.21253823 |
| 84 | inner ear receptor stereocilium organization (GO:0060122) | 3.20117835 |
| 85 | membrane depolarization (GO:0051899) | 3.19402993 |
| 86 | cerebellar Purkinje cell layer development (GO:0021680) | 3.18193941 |
| 87 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.18114077 |
| 88 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.13351464 |
| 89 | prepulse inhibition (GO:0060134) | 3.10941162 |
| 90 | neuromuscular process (GO:0050905) | 3.09910718 |
| 91 | presynaptic membrane organization (GO:0097090) | 3.07574746 |
| 92 | synapse assembly (GO:0007416) | 3.07505122 |
| 93 | multicellular organismal movement (GO:0050879) | 3.07395998 |
| 94 | musculoskeletal movement (GO:0050881) | 3.07395998 |
| 95 | long term synaptic depression (GO:0060292) | 3.05784193 |
| 96 | auditory behavior (GO:0031223) | 3.05589443 |
| 97 | proline transport (GO:0015824) | 3.05261039 |
| 98 | regulation of vesicle fusion (GO:0031338) | 3.04549518 |
| 99 | axonal fasciculation (GO:0007413) | 3.03570418 |
| 100 | neurofilament cytoskeleton organization (GO:0060052) | 3.03160947 |
| 101 | negative regulation of hormone metabolic process (GO:0032351) | 3.02949919 |
| 102 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.02949919 |
| 103 | regulation of neurotransmitter transport (GO:0051588) | 2.99095765 |
| 104 | mechanosensory behavior (GO:0007638) | 2.98051894 |
| 105 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.97394958 |
| 106 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.96858262 |
| 107 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.96858262 |
| 108 | presynaptic membrane assembly (GO:0097105) | 2.96752215 |
| 109 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.96252674 |
| 110 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96022397 |
| 111 | neuronal action potential (GO:0019228) | 2.93171907 |
| 112 | synapse organization (GO:0050808) | 2.92505769 |
| 113 | membrane repolarization (GO:0086009) | 2.91977527 |
| 114 | membrane hyperpolarization (GO:0060081) | 2.91425850 |
| 115 | postsynaptic membrane organization (GO:0001941) | 2.90754353 |
| 116 | neuron recognition (GO:0008038) | 2.89227805 |
| 117 | long-term synaptic potentiation (GO:0060291) | 2.86352225 |
| 118 | behavioral response to ethanol (GO:0048149) | 2.85268678 |
| 119 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.85073041 |
| 120 | positive regulation of potassium ion transport (GO:0043268) | 2.84686148 |
| 121 | positive regulation of fibroblast migration (GO:0010763) | 2.83445381 |
| 122 | indole-containing compound metabolic process (GO:0042430) | 2.81152814 |
| 123 | neuromuscular synaptic transmission (GO:0007274) | 2.81028705 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 2.78370876 |
| 125 | rhodopsin mediated signaling pathway (GO:0016056) | 2.77687366 |
| 126 | tryptophan catabolic process (GO:0006569) | 2.76231517 |
| 127 | indole-containing compound catabolic process (GO:0042436) | 2.76231517 |
| 128 | indolalkylamine catabolic process (GO:0046218) | 2.76231517 |
| 129 | aggressive behavior (GO:0002118) | 2.74012376 |
| 130 | startle response (GO:0001964) | 2.73226628 |
| 131 | reflex (GO:0060004) | 2.72914243 |
| 132 | axon ensheathment in central nervous system (GO:0032291) | 2.72451568 |
| 133 | central nervous system myelination (GO:0022010) | 2.72451568 |
| 134 | potassium ion transmembrane transport (GO:0071805) | 2.71435902 |
| 135 | cellular potassium ion transport (GO:0071804) | 2.71435902 |
| 136 | kynurenine metabolic process (GO:0070189) | 2.70044110 |
| 137 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.69186619 |
| 138 | protein polyglutamylation (GO:0018095) | 2.63902221 |
| 139 | retina layer formation (GO:0010842) | 2.63326148 |
| 140 | adult behavior (GO:0030534) | 2.62483864 |
| 141 | cochlea development (GO:0090102) | 2.62244840 |
| 142 | glycosphingolipid biosynthetic process (GO:0006688) | 2.61551930 |
| 143 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.61136678 |
| 144 | potassium ion transport (GO:0006813) | 2.60268265 |
| 145 | dopamine transport (GO:0015872) | 2.59143893 |
| 146 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.59078345 |
| 147 | protein localization to cilium (GO:0061512) | 2.57731853 |
| 148 | parturition (GO:0007567) | 2.56353257 |
| 149 | neurotransmitter metabolic process (GO:0042133) | 2.56005730 |
| 150 | * synaptic transmission (GO:0007268) | 2.54770707 |
| 151 | protein complex biogenesis (GO:0070271) | 2.53442786 |
| 152 | synaptic transmission, cholinergic (GO:0007271) | 2.52368164 |
| 153 | axoneme assembly (GO:0035082) | 2.51530392 |
| 154 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.49718562 |
| 155 | dopamine biosynthetic process (GO:0042416) | 2.49431315 |
| 156 | protein K11-linked deubiquitination (GO:0035871) | 2.47395005 |
| 157 | photoreceptor cell maintenance (GO:0045494) | 2.47189272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.60990876 |
| 2 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.49681712 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.23141197 |
| 4 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.16156385 |
| 5 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 3.15295187 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 3.15295187 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13522271 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07638642 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.91442998 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.80523546 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.74497038 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.73989181 |
| 13 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.67607275 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63566155 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.63253320 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.61170940 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.59581746 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.58598121 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.57391937 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.56425878 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56197400 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.47537977 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.41852111 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.39759342 |
| 25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.36648316 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35095368 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34769603 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.30417745 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29771437 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24240526 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.15167656 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13846964 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.06114902 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.04089217 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 2.03583458 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.99288100 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.91666497 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83021469 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82391603 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.80663411 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77950241 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.73607051 |
| 43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.69208871 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68640909 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.66966918 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.56531623 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56426352 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53644970 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.53250699 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51514676 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.51514676 |
| 52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.50228552 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49713315 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49022346 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47570504 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45804637 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44875843 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40398047 |
| 59 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40346373 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39616249 |
| 61 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.38677236 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37656363 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37297251 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36884225 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36884225 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34906970 |
| 67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.34757194 |
| 68 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.33685990 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.32325241 |
| 70 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31774421 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31116442 |
| 72 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30348140 |
| 73 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29869954 |
| 74 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.29487511 |
| 75 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28679993 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28123080 |
| 77 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27575233 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25668177 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24748298 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.24648109 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.24517985 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.24517985 |
| 83 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21211639 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21035820 |
| 85 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.20532439 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.20284868 |
| 87 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20157456 |
| 88 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19869903 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19859163 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19309779 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18903834 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18505659 |
| 93 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.18207391 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17890718 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.17388047 |
| 96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17031473 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13957030 |
| 98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13263314 |
| 99 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.13159356 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12733290 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11802253 |
| 102 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10638502 |
| 103 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09865156 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09755660 |
| 105 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.09300902 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08600497 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08176176 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08083292 |
| 109 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07167396 |
| 110 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07074898 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06477271 |
| 112 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06090588 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05776132 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04670198 |
| 115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02542607 |
| 116 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00965053 |
| 117 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00111124 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00050406 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98586905 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97546493 |
| 121 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96851992 |
| 122 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96437968 |
| 123 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.96189520 |
| 124 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95006637 |
| 125 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94871948 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94539853 |
| 127 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94401502 |
| 128 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92213326 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92129065 |
| 130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90122468 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89905764 |
| 132 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89374671 |
| 133 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.88814061 |
| 134 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88237313 |
| 135 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88141677 |
| 136 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87713951 |
| 137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87472682 |
| 138 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83097062 |
| 139 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.82900371 |
| 140 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82894575 |
| 141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81684517 |
| 142 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.81445572 |
| 143 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.81120754 |
| 144 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80582291 |
| 145 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.80265723 |
| 146 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79520277 |
| 147 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77955324 |
| 148 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76544661 |
| 149 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.76073679 |
| 150 | P300_19829295_ChIP-Seq_ESCs_Human | 0.75934467 |
| 151 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75258109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.66360066 |
| 2 | MP0009046_muscle_twitch | 4.71390084 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.04546211 |
| 4 | MP0008569_lethality_at_weaning | 3.25043280 |
| 5 | MP0009745_abnormal_behavioral_response | 3.09006261 |
| 6 | MP0002064_seizures | 3.07573947 |
| 7 | MP0003880_abnormal_central_pattern | 3.02414695 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.01819795 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.97619587 |
| 10 | MP0004270_analgesia | 2.91772982 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.82890492 |
| 12 | * MP0002272_abnormal_nervous_system | 2.82103257 |
| 13 | MP0001440_abnormal_grooming_behavior | 2.65832503 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.63864916 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.63802916 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.61915139 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.57414646 |
| 18 | MP0002067_abnormal_sensory_capabilities | 2.46338063 |
| 19 | MP0002736_abnormal_nociception_after | 2.44381455 |
| 20 | MP0002184_abnormal_innervation | 2.40905508 |
| 21 | MP0001486_abnormal_startle_reflex | 2.14413891 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.13987384 |
| 23 | MP0003329_amyloid_beta_deposits | 2.12968654 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.12194962 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.92954875 |
| 26 | MP0004142_abnormal_muscle_tone | 1.91662420 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.89040393 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.87244640 |
| 29 | MP0004885_abnormal_endolymph | 1.81866096 |
| 30 | MP0001970_abnormal_pain_threshold | 1.80961148 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.80477024 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77450323 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.75426982 |
| 34 | MP0005623_abnormal_meninges_morphology | 1.74693241 |
| 35 | MP0000955_abnormal_spinal_cord | 1.72294453 |
| 36 | MP0003195_calcinosis | 1.66718534 |
| 37 | MP0004742_abnormal_vestibular_system | 1.65682698 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.63408324 |
| 39 | MP0004924_abnormal_behavior | 1.63408324 |
| 40 | MP0004858_abnormal_nervous_system | 1.63054938 |
| 41 | MP0002066_abnormal_motor_capabilities/c | 1.57445181 |
| 42 | MP0000778_abnormal_nervous_system | 1.57435567 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.56598701 |
| 44 | MP0002102_abnormal_ear_morphology | 1.56294548 |
| 45 | MP0003632_abnormal_nervous_system | 1.55034978 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.54291106 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.52907448 |
| 48 | MP0003283_abnormal_digestive_organ | 1.43842617 |
| 49 | MP0004147_increased_porphyrin_level | 1.37374386 |
| 50 | MP0005253_abnormal_eye_physiology | 1.36014900 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.34888142 |
| 52 | MP0003122_maternal_imprinting | 1.30719917 |
| 53 | MP0003646_muscle_fatigue | 1.30020062 |
| 54 | MP0003879_abnormal_hair_cell | 1.28862727 |
| 55 | MP0006292_abnormal_olfactory_placode | 1.28115579 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.26522381 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 1.26321798 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.26002581 |
| 59 | MP0003631_nervous_system_phenotype | 1.25513499 |
| 60 | MP0003136_yellow_coat_color | 1.25208672 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.24776916 |
| 62 | MP0003633_abnormal_nervous_system | 1.21451660 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.20944024 |
| 64 | MP0000631_abnormal_neuroendocrine_gland | 1.19879632 |
| 65 | MP0002152_abnormal_brain_morphology | 1.19442571 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.18987855 |
| 67 | MP0006276_abnormal_autonomic_nervous | 1.18832869 |
| 68 | MP0002089_abnormal_postnatal_growth/wei | 1.17488837 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.17310057 |
| 70 | MP0001984_abnormal_olfaction | 1.14808334 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 1.10745407 |
| 72 | MP0000920_abnormal_myelination | 1.09877490 |
| 73 | MP0003121_genomic_imprinting | 1.08061894 |
| 74 | MP0000427_abnormal_hair_cycle | 1.06897565 |
| 75 | MP0000751_myopathy | 1.05734641 |
| 76 | MP0005410_abnormal_fertilization | 1.03020413 |
| 77 | MP0003045_fibrosis | 1.01588469 |
| 78 | MP0004133_heterotaxia | 0.99650683 |
| 79 | MP0002160_abnormal_reproductive_system | 0.99047898 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.98701134 |
| 81 | MP0001348_abnormal_lacrimal_gland | 0.97336136 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 0.96497802 |
| 83 | MP0004233_abnormal_muscle_weight | 0.91725636 |
| 84 | MP0003690_abnormal_glial_cell | 0.90858806 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.90627625 |
| 86 | MP0003634_abnormal_glial_cell | 0.89241190 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.88646596 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.87212193 |
| 89 | MP0001177_atelectasis | 0.87183719 |
| 90 | MP0000604_amyloidosis | 0.86820652 |
| 91 | MP0001905_abnormal_dopamine_level | 0.86699134 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.86498092 |
| 93 | MP0002229_neurodegeneration | 0.86448858 |
| 94 | MP0008872_abnormal_physiological_respon | 0.83935764 |
| 95 | MP0002938_white_spotting | 0.82431354 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.81794415 |
| 97 | MP0002234_abnormal_pharynx_morphology | 0.80802355 |
| 98 | MP0003698_abnormal_male_reproductive | 0.78852933 |
| 99 | MP0004484_altered_response_of | 0.78451578 |
| 100 | MP0005389_reproductive_system_phenotype | 0.78380648 |
| 101 | MP0002069_abnormal_eating/drinking_beha | 0.76569306 |
| 102 | MP0005187_abnormal_penis_morphology | 0.76058807 |
| 103 | MP0000747_muscle_weakness | 0.74820468 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.74173618 |
| 105 | MP0005503_abnormal_tendon_morphology | 0.73339220 |
| 106 | MP0001529_abnormal_vocalization | 0.72719593 |
| 107 | MP0003011_delayed_dark_adaptation | 0.71622135 |
| 108 | MP0000026_abnormal_inner_ear | 0.70373460 |
| 109 | MP0004043_abnormal_pH_regulation | 0.70301896 |
| 110 | MP0003279_aneurysm | 0.70284803 |
| 111 | MP0003787_abnormal_imprinting | 0.70152567 |
| 112 | MP0005195_abnormal_posterior_eye | 0.68778835 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.68114625 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.67399420 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.67307142 |
| 116 | MP0004085_abnormal_heartbeat | 0.66147858 |
| 117 | MP0003861_abnormal_nervous_system | 0.64837229 |
| 118 | MP0002928_abnormal_bile_duct | 0.64243930 |
| 119 | MP0001958_emphysema | 0.64187205 |
| 120 | MP0010769_abnormal_survival | 0.64085392 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.62029975 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.61949607 |
| 123 | MP0008874_decreased_physiological_sensi | 0.61689491 |
| 124 | MP0003385_abnormal_body_wall | 0.61655896 |
| 125 | MP0001188_hyperpigmentation | 0.61626717 |
| 126 | MP0000569_abnormal_digit_pigmentation | 0.61542239 |
| 127 | MP0005083_abnormal_biliary_tract | 0.61022872 |
| 128 | MP0010768_mortality/aging | 0.60504445 |
| 129 | MP0005394_taste/olfaction_phenotype | 0.59528686 |
| 130 | MP0005499_abnormal_olfactory_system | 0.59528686 |
| 131 | MP0000383_abnormal_hair_follicle | 0.59521172 |
| 132 | MP0005171_absent_coat_pigmentation | 0.59294638 |
| 133 | MP0002082_postnatal_lethality | 0.58737856 |
| 134 | MP0010770_preweaning_lethality | 0.58737856 |
| 135 | MP0002751_abnormal_autonomic_nervous | 0.58608314 |
| 136 | MP0001943_abnormal_respiration | 0.57971299 |
| 137 | MP0001485_abnormal_pinna_reflex | 0.57955044 |
| 138 | MP0000003_abnormal_adipose_tissue | 0.53443721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Action tremor (HP:0002345) | 6.76113948 |
| 2 | Progressive cerebellar ataxia (HP:0002073) | 6.52973048 |
| 3 | Visual hallucinations (HP:0002367) | 5.63166580 |
| 4 | Focal motor seizures (HP:0011153) | 5.31115144 |
| 5 | Myokymia (HP:0002411) | 5.13185495 |
| 6 | Focal seizures (HP:0007359) | 5.09147073 |
| 7 | Atonic seizures (HP:0010819) | 4.94214833 |
| 8 | Gaze-evoked nystagmus (HP:0000640) | 4.86467096 |
| 9 | Scanning speech (HP:0002168) | 4.53024055 |
| 10 | Dysmetric saccades (HP:0000641) | 4.44872691 |
| 11 | Dysdiadochokinesis (HP:0002075) | 4.34540638 |
| 12 | Hemiplegia (HP:0002301) | 4.22031818 |
| 13 | Impaired smooth pursuit (HP:0007772) | 4.14349832 |
| 14 | Febrile seizures (HP:0002373) | 3.96337185 |
| 15 | Intention tremor (HP:0002080) | 3.84162335 |
| 16 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.83303724 |
| 17 | Genetic anticipation (HP:0003743) | 3.78245417 |
| 18 | Absence seizures (HP:0002121) | 3.74834059 |
| 19 | Dysmetria (HP:0001310) | 3.69475487 |
| 20 | Hyperventilation (HP:0002883) | 3.61491657 |
| 21 | Epileptic encephalopathy (HP:0200134) | 3.60731626 |
| 22 | Broad-based gait (HP:0002136) | 3.57943692 |
| 23 | Abnormality of the lower motor neuron (HP:0002366) | 3.57163271 |
| 24 | Truncal ataxia (HP:0002078) | 3.56814373 |
| 25 | Pancreatic cysts (HP:0001737) | 3.53774860 |
| 26 | Abnormality of binocular vision (HP:0011514) | 3.51446118 |
| 27 | Diplopia (HP:0000651) | 3.51446118 |
| 28 | Hemiparesis (HP:0001269) | 3.42204455 |
| 29 | Pancreatic fibrosis (HP:0100732) | 3.36137106 |
| 30 | True hermaphroditism (HP:0010459) | 3.26846243 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 3.26294758 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 3.26294758 |
| 33 | Tetraplegia (HP:0002445) | 3.19270274 |
| 34 | Dialeptic seizures (HP:0011146) | 3.17565200 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 3.10022888 |
| 36 | Postural tremor (HP:0002174) | 3.08517409 |
| 37 | Congenital stationary night blindness (HP:0007642) | 3.07985495 |
| 38 | Shallow orbits (HP:0000586) | 3.06156518 |
| 39 | Nephronophthisis (HP:0000090) | 3.03111805 |
| 40 | Type II lissencephaly (HP:0007260) | 2.99499279 |
| 41 | Poor eye contact (HP:0000817) | 2.93762622 |
| 42 | Horizontal nystagmus (HP:0000666) | 2.93062319 |
| 43 | Supranuclear gaze palsy (HP:0000605) | 2.92756592 |
| 44 | Status epilepticus (HP:0002133) | 2.92605641 |
| 45 | Depression (HP:0000716) | 2.91007778 |
| 46 | Annular pancreas (HP:0001734) | 2.78794797 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.73759455 |
| 48 | Impaired social interactions (HP:0000735) | 2.70722549 |
| 49 | Abnormal social behavior (HP:0012433) | 2.70722549 |
| 50 | Amyotrophic lateral sclerosis (HP:0007354) | 2.66392408 |
| 51 | Abnormality of saccadic eye movements (HP:0000570) | 2.62981383 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 2.62048346 |
| 53 | Medial flaring of the eyebrow (HP:0010747) | 2.61755393 |
| 54 | Ventricular fibrillation (HP:0001663) | 2.61576399 |
| 55 | Inability to walk (HP:0002540) | 2.56758220 |
| 56 | Mutism (HP:0002300) | 2.55026466 |
| 57 | Limb ataxia (HP:0002070) | 2.52520929 |
| 58 | Broad metatarsal (HP:0001783) | 2.52415703 |
| 59 | Anxiety (HP:0000739) | 2.51678862 |
| 60 | Attenuation of retinal blood vessels (HP:0007843) | 2.51636837 |
| 61 | Agitation (HP:0000713) | 2.49875620 |
| 62 | Abnormality of the renal cortex (HP:0011035) | 2.48796047 |
| 63 | Progressive inability to walk (HP:0002505) | 2.48712307 |
| 64 | Acute necrotizing encephalopathy (HP:0006965) | 2.47762594 |
| 65 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.46312272 |
| 66 | Myotonia (HP:0002486) | 2.45968975 |
| 67 | Abnormality of the corticospinal tract (HP:0002492) | 2.42934284 |
| 68 | Cystic liver disease (HP:0006706) | 2.38483256 |
| 69 | Limb dystonia (HP:0002451) | 2.36890519 |
| 70 | Hand muscle atrophy (HP:0009130) | 2.36647162 |
| 71 | Progressive macrocephaly (HP:0004481) | 2.36120117 |
| 72 | Abnormality of the labia minora (HP:0012880) | 2.33144190 |
| 73 | Decreased central vision (HP:0007663) | 2.31826170 |
| 74 | Gait imbalance (HP:0002141) | 2.31490352 |
| 75 | Ankle clonus (HP:0011448) | 2.28318943 |
| 76 | Lower limb asymmetry (HP:0100559) | 2.26460722 |
| 77 | Chronic hepatic failure (HP:0100626) | 2.26311405 |
| 78 | Gait ataxia (HP:0002066) | 2.25918076 |
| 79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.25640697 |
| 80 | Abolished electroretinogram (ERG) (HP:0000550) | 2.24843211 |
| 81 | Abnormal drinking behavior (HP:0030082) | 2.23096850 |
| 82 | Polydipsia (HP:0001959) | 2.23096850 |
| 83 | Mitochondrial inheritance (HP:0001427) | 2.20895234 |
| 84 | Spastic gait (HP:0002064) | 2.20520016 |
| 85 | Pointed chin (HP:0000307) | 2.20185946 |
| 86 | Protrusio acetabuli (HP:0003179) | 2.16906607 |
| 87 | Postural instability (HP:0002172) | 2.15760802 |
| 88 | Acute encephalopathy (HP:0006846) | 2.15071351 |
| 89 | Spinal canal stenosis (HP:0003416) | 2.12004399 |
| 90 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11792633 |
| 91 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.11609413 |
| 92 | Narrow nasal bridge (HP:0000446) | 2.09931545 |
| 93 | Neuronal loss in central nervous system (HP:0002529) | 2.09559904 |
| 94 | Upper limb amyotrophy (HP:0009129) | 2.08908668 |
| 95 | Distal upper limb amyotrophy (HP:0007149) | 2.08908668 |
| 96 | Cerebellar dysplasia (HP:0007033) | 2.08596564 |
| 97 | Slow progression (HP:0003677) | 2.07579108 |
| 98 | Increased CSF lactate (HP:0002490) | 2.05452152 |
| 99 | Stereotypic behavior (HP:0000733) | 2.03803617 |
| 100 | Congenital primary aphakia (HP:0007707) | 2.03677832 |
| 101 | Optic nerve hypoplasia (HP:0000609) | 2.03534086 |
| 102 | Polyphagia (HP:0002591) | 2.03190819 |
| 103 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02976360 |
| 104 | Absent speech (HP:0001344) | 2.02045623 |
| 105 | Psychosis (HP:0000709) | 2.02032024 |
| 106 | Bundle branch block (HP:0011710) | 2.01730534 |
| 107 | Lissencephaly (HP:0001339) | 2.00874065 |
| 108 | Hypothermia (HP:0002045) | 2.00105212 |
| 109 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.97674105 |
| 110 | Tubular atrophy (HP:0000092) | 1.96002061 |
| 111 | Achilles tendon contracture (HP:0001771) | 1.95789669 |
| 112 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95416184 |
| 113 | Pheochromocytoma (HP:0002666) | 1.93458013 |
| 114 | Pendular nystagmus (HP:0012043) | 1.92257853 |
| 115 | Premature rupture of membranes (HP:0001788) | 1.91613437 |
| 116 | Large for gestational age (HP:0001520) | 1.89616845 |
| 117 | Hypoventilation (HP:0002791) | 1.89457201 |
| 118 | Protruding tongue (HP:0010808) | 1.86709834 |
| 119 | Genital tract atresia (HP:0001827) | 1.85874302 |
| 120 | Stomach cancer (HP:0012126) | 1.85864090 |
| 121 | Renal cortical cysts (HP:0000803) | 1.85673344 |
| 122 | Neurofibrillary tangles (HP:0002185) | 1.84879274 |
| 123 | Abnormality of macular pigmentation (HP:0008002) | 1.84579124 |
| 124 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84451224 |
| 125 | Megalencephaly (HP:0001355) | 1.84061312 |
| 126 | Neoplasm of the heart (HP:0100544) | 1.84051298 |
| 127 | Aqueductal stenosis (HP:0002410) | 1.81805237 |
| 128 | Sclerocornea (HP:0000647) | 1.81698169 |
| 129 | Excessive salivation (HP:0003781) | 1.80065578 |
| 130 | Drooling (HP:0002307) | 1.80065578 |
| 131 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.79647369 |
| 132 | Abnormality of alanine metabolism (HP:0010916) | 1.79647369 |
| 133 | Hyperalaninemia (HP:0003348) | 1.79647369 |
| 134 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.78964440 |
| 135 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.78249547 |
| 136 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.78249547 |
| 137 | Cerebral inclusion bodies (HP:0100314) | 1.78103003 |
| 138 | Vaginal atresia (HP:0000148) | 1.77609056 |
| 139 | Retinal dysplasia (HP:0007973) | 1.77060503 |
| 140 | Optic disc pallor (HP:0000543) | 1.76714814 |
| 141 | Overgrowth (HP:0001548) | 1.75739698 |
| 142 | Oligodactyly (hands) (HP:0001180) | 1.75327113 |
| 143 | Hepatocellular necrosis (HP:0001404) | 1.74640551 |
| 144 | Clonus (HP:0002169) | 1.74370296 |
| 145 | Polyuria (HP:0000103) | 1.74328683 |
| 146 | Bowel diverticulosis (HP:0005222) | 1.74111719 |
| 147 | Split foot (HP:0001839) | 1.72343585 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.71301356 |
| 149 | Failure to thrive in infancy (HP:0001531) | 1.71087381 |
| 150 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.69035840 |
| 151 | Intestinal atresia (HP:0011100) | 1.68950686 |
| 152 | Furrowed tongue (HP:0000221) | 1.68874441 |
| 153 | Insomnia (HP:0100785) | 1.68807876 |
| 154 | Increased corneal curvature (HP:0100692) | 1.68717574 |
| 155 | Keratoconus (HP:0000563) | 1.68717574 |
| 156 | Amblyopia (HP:0000646) | 1.68406026 |
| 157 | Anencephaly (HP:0002323) | 1.67572889 |
| 158 | Bradykinesia (HP:0002067) | 1.67303226 |
| 159 | Incomplete penetrance (HP:0003829) | 1.67007173 |
| 160 | Fetal akinesia sequence (HP:0001989) | 1.65527673 |
| 161 | EEG with generalized epileptiform discharges (HP:0011198) | 1.64835908 |
| 162 | Epileptiform EEG discharges (HP:0011182) | 1.64399840 |
| 163 | Generalized hypotonia (HP:0001290) | 1.63536897 |
| 164 | Hypoplastic nipples (HP:0002557) | 1.62800333 |
| 165 | Hypsarrhythmia (HP:0002521) | 1.62262043 |
| 166 | Broad ribs (HP:0000885) | 1.61650418 |
| 167 | Urinary urgency (HP:0000012) | 1.61468443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.31345605 |
| 2 | CAMKK2 | 3.98750608 |
| 3 | NTRK3 | 3.76386258 |
| 4 | RIPK1 | 3.24861177 |
| 5 | MAP3K9 | 2.99671518 |
| 6 | MINK1 | 2.82030777 |
| 7 | MAP3K4 | 2.74522373 |
| 8 | CAMKK1 | 2.63288946 |
| 9 | ADRBK2 | 2.60395824 |
| 10 | MAP4K2 | 2.59337489 |
| 11 | MARK1 | 2.56637269 |
| 12 | PAK6 | 2.43077061 |
| 13 | WNK1 | 2.37827719 |
| 14 | BMPR1B | 2.36686411 |
| 15 | CDK19 | 2.27631376 |
| 16 | ZAK | 2.26325487 |
| 17 | WNK3 | 2.22874051 |
| 18 | NTRK2 | 2.17459236 |
| 19 | STK38 | 1.99004032 |
| 20 | MAP2K4 | 1.93349546 |
| 21 | MAP2K7 | 1.89001901 |
| 22 | DAPK2 | 1.88763384 |
| 23 | TLK1 | 1.80192161 |
| 24 | TYRO3 | 1.70364219 |
| 25 | NUAK1 | 1.69383522 |
| 26 | GRK1 | 1.66425677 |
| 27 | INSRR | 1.60597075 |
| 28 | TAOK3 | 1.58048239 |
| 29 | PNCK | 1.52183543 |
| 30 | PRKCG | 1.48455885 |
| 31 | ACVR1B | 1.47241240 |
| 32 | LATS2 | 1.42661498 |
| 33 | PRPF4B | 1.41950218 |
| 34 | NTRK1 | 1.39344518 |
| 35 | PLK2 | 1.31863369 |
| 36 | KSR2 | 1.31651072 |
| 37 | SIK2 | 1.31568013 |
| 38 | UHMK1 | 1.30440579 |
| 39 | STK39 | 1.26919966 |
| 40 | CDK5 | 1.25015870 |
| 41 | CDK15 | 1.23515634 |
| 42 | GRK5 | 1.23506210 |
| 43 | CSNK1G2 | 1.21965426 |
| 44 | CDK18 | 1.19328380 |
| 45 | WNK4 | 1.18816615 |
| 46 | PRKCH | 1.16911637 |
| 47 | ALK | 1.16502042 |
| 48 | KSR1 | 1.13509800 |
| 49 | CAMK1 | 1.12694550 |
| 50 | CSNK1G1 | 1.12294823 |
| 51 | PHKG1 | 1.12167427 |
| 52 | PHKG2 | 1.12167427 |
| 53 | SGK494 | 1.10205378 |
| 54 | SGK223 | 1.10205378 |
| 55 | STK11 | 1.09659912 |
| 56 | CDK14 | 1.09495138 |
| 57 | CDK11A | 1.09379091 |
| 58 | MKNK2 | 1.09039910 |
| 59 | PRKCE | 1.08699667 |
| 60 | OXSR1 | 1.08417147 |
| 61 | CASK | 1.08090775 |
| 62 | RIPK4 | 1.06253248 |
| 63 | CSNK1G3 | 1.05366903 |
| 64 | MAPK13 | 1.04062289 |
| 65 | TRIM28 | 1.03012460 |
| 66 | PAK3 | 1.02970583 |
| 67 | FGFR2 | 0.97354153 |
| 68 | PTK2 | 0.93553199 |
| 69 | PTK6 | 0.93121025 |
| 70 | CSNK1A1L | 0.93087707 |
| 71 | MAPKAPK5 | 0.92761334 |
| 72 | CAMK2G | 0.91804121 |
| 73 | STK38L | 0.90615708 |
| 74 | DDR2 | 0.90321342 |
| 75 | CDC42BPA | 0.90058823 |
| 76 | PKN1 | 0.88144133 |
| 77 | RET | 0.86984737 |
| 78 | CAMK4 | 0.86519036 |
| 79 | SGK2 | 0.86209876 |
| 80 | SGK3 | 0.85813717 |
| 81 | EPHA4 | 0.85193056 |
| 82 | DYRK2 | 0.85134180 |
| 83 | CAMK1G | 0.84079496 |
| 84 | ROCK2 | 0.84021788 |
| 85 | CAMK2B | 0.83194898 |
| 86 | ADRBK1 | 0.82941826 |
| 87 | LMTK2 | 0.81081062 |
| 88 | CAMK2A | 0.80949071 |
| 89 | PRKD3 | 0.80409167 |
| 90 | TNIK | 0.76701485 |
| 91 | AKT3 | 0.75245628 |
| 92 | TRIB3 | 0.73182525 |
| 93 | TAF1 | 0.73161066 |
| 94 | PDGFRA | 0.73082885 |
| 95 | DYRK1A | 0.72972896 |
| 96 | MAP3K12 | 0.72534547 |
| 97 | CAMK2D | 0.69705238 |
| 98 | VRK1 | 0.69029191 |
| 99 | SCYL2 | 0.68246323 |
| 100 | CCNB1 | 0.66164888 |
| 101 | DAPK1 | 0.66057616 |
| 102 | TXK | 0.65802974 |
| 103 | LIMK1 | 0.65743174 |
| 104 | PINK1 | 0.65599865 |
| 105 | ARAF | 0.63160278 |
| 106 | MARK2 | 0.63016046 |
| 107 | FYN | 0.62238129 |
| 108 | BCR | 0.60212703 |
| 109 | TAOK1 | 0.60024547 |
| 110 | MAP2K6 | 0.59890068 |
| 111 | PTK2B | 0.59783308 |
| 112 | PDK1 | 0.58475142 |
| 113 | ERBB3 | 0.57558194 |
| 114 | SGK1 | 0.57521460 |
| 115 | CSNK1A1 | 0.57418122 |
| 116 | PDPK1 | 0.56098312 |
| 117 | MUSK | 0.56082949 |
| 118 | FER | 0.54580899 |
| 119 | RPS6KA3 | 0.54018705 |
| 120 | PLK3 | 0.53995180 |
| 121 | PRKG1 | 0.53510090 |
| 122 | TIE1 | 0.53102705 |
| 123 | PRKCZ | 0.51515806 |
| 124 | BMX | 0.51248437 |
| 125 | PRKCA | 0.49116664 |
| 126 | CSNK1D | 0.48880082 |
| 127 | EPHB1 | 0.47806554 |
| 128 | PRKCI | 0.46384324 |
| 129 | SRC | 0.44781445 |
| 130 | NEK6 | 0.44242427 |
| 131 | FES | 0.44195239 |
| 132 | MAPKAPK3 | 0.43894378 |
| 133 | MAP3K2 | 0.43153623 |
| 134 | TNK2 | 0.43106207 |
| 135 | BRSK2 | 0.41683709 |
| 136 | DAPK3 | 0.41613890 |
| 137 | PRKCQ | 0.40335060 |
| 138 | NEK1 | 0.39518085 |
| 139 | PRKACB | 0.39421228 |
| 140 | TGFBR1 | 0.37935149 |
| 141 | RPS6KA5 | 0.36954584 |
| 142 | MKNK1 | 0.36725145 |
| 143 | MAPK12 | 0.36529825 |
| 144 | MAPK10 | 0.36358921 |
| 145 | PRKDC | 0.35626886 |
| 146 | PRKACA | 0.35416274 |
| 147 | HIPK2 | 0.35326851 |
| 148 | PRKAA1 | 0.34349199 |
| 149 | CDK3 | 0.33596422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.37067070 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.01512960 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.90392611 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.85860915 |
| 5 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.83818658 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71095941 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.67594298 |
| 8 | Long-term depression_Homo sapiens_hsa04730 | 2.60557320 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.49919567 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36578136 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.28739059 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.22292010 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.20701368 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11914143 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.04775911 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.89934166 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88440334 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.88435875 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88122295 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79345623 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.73432293 |
| 22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.68567099 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.66913684 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.65132814 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.63595001 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62650557 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.53898061 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52822735 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51733351 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46821966 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46077599 |
| 32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44521868 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43507424 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.42065446 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41244091 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.40738739 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35006509 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33821712 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.33231869 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33196088 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.30234921 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.29354813 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24893860 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 1.23899224 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.19582325 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18357336 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.16599836 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13760080 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09994085 |
| 50 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08200006 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08016071 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05546112 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02227255 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01912965 |
| 55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99754326 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98017212 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96309478 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95977926 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94919282 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.93984652 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.93789861 |
| 62 | Protein export_Homo sapiens_hsa03060 | 0.93158408 |
| 63 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91909010 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91166554 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90563295 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.90501662 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88602853 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.87717719 |
| 69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87569357 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87176190 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86939613 |
| 72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86786812 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.84952330 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.84273692 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83866425 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80975166 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78247833 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.77578412 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74860490 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74058373 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72235667 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71512764 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69323892 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68994614 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67997638 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67234505 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64893723 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.64491393 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61537978 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60536797 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60054451 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59053283 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58371091 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56764306 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56045781 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54524149 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53558811 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53105794 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52973169 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52601782 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52456002 |
| 102 | RNA degradation_Homo sapiens_hsa03018 | 0.52002287 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51042663 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50627156 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50094443 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49336842 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48835502 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48192157 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.46923051 |
| 110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45878348 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45096990 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45012066 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.43686569 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43420020 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43244054 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43199353 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42503037 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41829349 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41602215 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39929118 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39873770 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39195781 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38472003 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38023178 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37299914 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37258550 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37198615 |
| 128 | Focal adhesion_Homo sapiens_hsa04510 | 0.37146602 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36781179 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36689125 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36505173 |
| 132 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35154851 |
| 133 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.35117366 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.35109424 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34132637 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.33549334 |
| 137 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33451648 |
| 138 | Alcoholism_Homo sapiens_hsa05034 | 0.32648057 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31589261 |
| 140 | Purine metabolism_Homo sapiens_hsa00230 | 0.31267917 |
| 141 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30864921 |
| 142 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30606269 |
| 143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29177847 |
| 144 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28597023 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28511438 |
| 146 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28483927 |

